breastcancerlogo

PMRT/RNI Decision Tool in Patients with Neoadyuvant Treatment

This software computes the algorithm used at MD Anderson Cancer Center when making desicions on whether PMRT is indicated in the scenario that neoadyuvant chemotherapy was used. This algorithm was developed at the University of Texas M. D. Anderson Cancer Center and is in the process of internal validation.

Initial size of the tumor (in centimeters) ^*

Menopausal Status ^*

Premenopausal Postmenopausal

Location^*

Medial Central Lateral

LVSI^*

Yes No

Ki-67^*

Grade^*

1 2 3

% of Positive Estrogen Receptor^*

Her 2 neu status^*

Positive Negative

Number of clinical positive lymph nodes^*

Number of pathological positive nodes^*

Was there a pathological complete response?^*

Yes No

Based on the data we would recommend: